Uncommon Cents Investing LLC Sells 755 Shares of Fresenius Medical Care AG (NYSE:FMS)

Uncommon Cents Investing LLC lessened its stake in Fresenius Medical Care AG (NYSE:FMS) by 1.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 40,625 shares of the company’s stock after selling 755 shares during the quarter. Uncommon Cents Investing LLC’s holdings in Fresenius Medical Care were worth $920,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Creative Planning lifted its position in shares of Fresenius Medical Care by 18.9% in the second quarter. Creative Planning now owns 40,140 shares of the company’s stock worth $766,000 after buying an additional 6,373 shares in the last quarter. Verition Fund Management LLC bought a new position in shares of Fresenius Medical Care during the 3rd quarter valued at approximately $237,000. Charles Schwab Investment Management Inc. grew its holdings in shares of Fresenius Medical Care by 11.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 22,161 shares of the company’s stock valued at $472,000 after purchasing an additional 2,233 shares in the last quarter. Quantinno Capital Management LP increased its position in Fresenius Medical Care by 78.9% in the third quarter. Quantinno Capital Management LP now owns 110,078 shares of the company’s stock worth $2,345,000 after purchasing an additional 48,554 shares during the last quarter. Finally, MML Investors Services LLC raised its stake in Fresenius Medical Care by 5.3% during the third quarter. MML Investors Services LLC now owns 15,019 shares of the company’s stock valued at $320,000 after purchasing an additional 753 shares in the last quarter. Institutional investors own 8.37% of the company’s stock.

Fresenius Medical Care Trading Down 0.3 %

FMS opened at $23.09 on Monday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37. The stock’s 50 day moving average price is $22.70 and its 200-day moving average price is $20.90. Fresenius Medical Care AG has a one year low of $17.93 and a one year high of $24.31. The stock has a market cap of $13.55 billion, a price-to-earnings ratio of 19.08, a P/E/G ratio of 0.72 and a beta of 0.92.

Analyst Ratings Changes

A number of research firms have recently weighed in on FMS. StockNews.com began coverage on shares of Fresenius Medical Care in a report on Friday, January 3rd. They issued a “strong-buy” rating on the stock. Berenberg Bank started coverage on Fresenius Medical Care in a research note on Wednesday, November 6th. They issued a “buy” rating and a $25.60 price objective for the company. Truist Financial lifted their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Finally, Bank of America upgraded Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a report on Monday, December 2nd.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.